Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
Carilion Clinic, serving over 1 million people in Virginia, has partnered with BD (NYSE: BDX) to become the first health system in Virginia and the Southeastern U.S. to implement needle-free blood draws using the BD® PIVO™ Pro Blood Collection Device.
The technology allows clinicians to draw blood through existing peripheral IV catheter lines, reducing multiple needlesticks, pain, and anxiety for patients. According to a Harris Poll, 51% of Americans report some fear of needles, with 31% specifically fearing multiple needle insertions.
The implementation begins at Carilion Roanoke Memorial Hospital with plans to expand to other Carilion facilities throughout the year. This initiative aims to improve patient care quality, reduce needlestick injuries, and streamline clinical workflows while minimizing complications that could lead to redraws and care delays.
Carilion Clinic, che serve oltre 1 milione di persone in Virginia, ha stretto una partnership con BD (NYSE: BDX) per diventare il primo sistema sanitario in Virginia e nel sud-est degli Stati Uniti a implementare prelievi di sangue senza ago utilizzando il Dispositivo per la Raccolta del Sangue BD® PIVO™ Pro.
Questa tecnologia consente ai medici di prelevare sangue attraverso le linee di cateteri venosi periferici esistenti, riducendo la necessità di più punture, il dolore e l'ansia per i pazienti. Secondo un sondaggio di Harris, il 51% degli americani riporta una certa paura degli aghi, con il 31% che teme specificamente le inserzioni multiple di aghi.
L'implementazione inizia presso il Carilion Roanoke Memorial Hospital, con piani di espansione verso altre strutture Carilion nel corso dell'anno. Questa iniziativa mira a migliorare la qualità dell'assistenza ai pazienti, ridurre gli infortuni da punture e semplificare i flussi di lavoro clinici, minimizzando nel contempo le complicazioni che potrebbero portare a ripetuti prelievi e ritardi nell'assistenza.
Carilion Clinic, que atiende a más de 1 millón de personas en Virginia, se ha asociado con BD (NYSE: BDX) para convertirse en el primer sistema de salud en Virginia y en el sureste de EE. UU. en implementar extracciones de sangre sin aguja utilizando el Dispositivo de Recolección de Sangre BD® PIVO™ Pro.
Esta tecnología permite a los clínicos extraer sangre a través de líneas de catéter IV periférico existentes, reduciendo las múltiples punciones, el dolor y la ansiedad para los pacientes. Según una encuesta de Harris, el 51% de los estadounidenses reporta algún miedo a las agujas, siendo el 31% el que teme específicamente las inserciones múltiples de agujas.
La implementación comienza en el Carilion Roanoke Memorial Hospital, con planes de expandirse a otras instalaciones de Carilion durante el año. Esta iniciativa tiene como objetivo mejorar la calidad de la atención al paciente, reducir las lesiones por punciones y optimizar los flujos de trabajo clínicos, minimizando al mismo tiempo las complicaciones que podrían llevar a nuevas extracciones y retrasos en la atención.
Carilion Clinic는 버지니아에서 100만명이 넘는 사람들에게 서비스를 제공하며, BD (NYSE: BDX)와 협력하여 버지니아 및 미국 동남부 최초로 바늘 없는 혈액 채취를 BD® PIVO™ Pro 혈액 채취 장치를 통해 시행하게 되었습니다.
이 기술은 의료진이 기존의 말초 IV 카테터 라인을 통해 혈액을 채취할 수 있도록 하여 여러 번의 바늘 사용, 통증 및 환자의 불안을 줄여줍니다. Harris Poll에 따르면, 미국인의 51%가 바늘에 대한 두려움을 느끼며, 그 중 31%는 특히 여러 번의 바늘 삽입을 두려워하고 있습니다.
이행은 Carilion Roanoke Memorial Hospital에서 시작되며, 연중 다른 Carilion 시설로 확장할 계획입니다. 이 이니셔티브는 환자 치료 품질을 개선하고, 바늘 침해 부상을 줄이며, 임상 작업 흐름을 간소화하고, 재채혈 및 치료 지연으로 이어질 수 있는 합병증을 최소화하는 것을 목표로 합니다.
Carilion Clinic, qui dessert plus de 1 million de personnes en Virginie, s'est associée à BD (NYSE: BDX) pour devenir le premier système de santé en Virginie et dans le sud-est des États-Unis à mettre en œuvre des prélèvements sanguins sans aiguille en utilisant le Dispositif de collecte de sang BD® PIVO™ Pro.
Cette technologie permet aux cliniciens de prélever du sang par les lignes de cathéter IV périphériques existantes, réduisant ainsi les multiples piqûres, la douleur et l'anxiété des patients. Selon un sondage Harris, 51 % des Américains déclarent éprouver une certaine peur des aiguilles, dont 31 % craignent spécifiquement les insertions multiples d'aiguilles.
L'implémentation débute au Carilion Roanoke Memorial Hospital, avec des plans d'expansion vers d'autres établissements Carilion au cours de l'année. Cette initiative vise à améliorer la qualité des soins aux patients, à réduire les blessures par piqûres et à rationaliser les workflows cliniques tout en minimisant les complications pouvant entraîner des prélèvements répétés et des retards dans les soins.
Carilion Clinic, die über 1 Million Menschen in Virginia behandelt, hat sich mit BD (NYSE: BDX) zusammengetan, um das erste Gesundheitssystem in Virginia und im Südosten der USA zu werden, das nadel-freie Blutentnahmen mit dem BD® PIVO™ Pro Blutentnahmegerät implementiert.
Diese Technologie ermöglicht es den Medizinern, Blut über bereits vorhandene periphere IV-Katheterleitungen zu entnehmen, wodurch die Anzahl der Nadelstiche, Schmerzen und Ängste der Patienten reduziert werden. Laut einer Harris-Umfrage berichten 51% der Amerikaner von einer gewissen Angst vor Nadeln, wobei 31% spezifisch vor mehrfachen Nadelstichen Angst haben.
Die Implementierung beginnt im Carilion Roanoke Memorial Hospital, mit Plänen zur Expansion auf andere Carilion-Einrichtungen im Laufe des Jahres. Diese Initiative zielt darauf ab, die Qualität der Patientenversorgung zu verbessern, Verletzungen durch Nadelstiche zu reduzieren und klinische Arbeitsabläufe zu optimieren, während gleichzeitig Komplikationen minimiert werden, die zu Nachentnahmen und Verzögerungen bei der Versorgung führen könnten.
- First-mover advantage in Virginia and Southeastern U.S. for needle-free blood collection technology
- Potential for improved clinical workflow efficiency and reduced care delays
- Addresses a significant market need (51% of Americans report needle fear)
- initial rollout to only one hospital location
- Implementation costs and training requirements not disclosed
Insights
The implementation of BD's PIVO Pro blood collection device at Carilion Clinic marks a strategic market expansion in the vascular access segment, which represents a significant growth opportunity in the $10+ billion global blood collection devices market. This first-in-state deployment serves as a important reference site for BD in the Southeastern U.S., potentially accelerating regional adoption.
The technology addresses a widespread clinical challenge, considering that blood draws affect nearly every hospitalized patient daily. With 51% of Americans reporting needle fear, this solution directly addresses a major patient satisfaction metric that hospitals are increasingly focused on. The market opportunity is substantial given that there are thousands of hospitals in the U.S. alone that could potentially adopt this technology.
From an investor perspective, three key factors make this development noteworthy:
- Revenue Potential: The technology could drive recurring revenue through both device sales and associated consumables
- Market Leadership: This strengthens BD's position in vascular access solutions, protecting market share against emerging competitors
- ESG Considerations: The focus on patient experience and healthcare worker safety aligns with growing ESG investment criteria
Looking ahead, successful implementation at Carilion could accelerate adoption across other healthcare systems. The planned rollout to additional Carilion hospitals throughout the year provides a clear pathway for near-term revenue growth in this product line. However, investors should monitor adoption rates, reimbursement policies and potential competition in this space.
The advanced PIVO™ Pro Technology allows clinicians to use a patient's existing peripheral IV catheter line for blood draws, leading to fewer needlesticks and less pain and anxiety for many patients. It also reduces the risk of needlestick injuries and streamlines clinical workflows, minimizing traditional IV and blood collection complications that result in redraws and potential delays in patient care.1,2
"We are excited to be the first in
Traditional blood draws by venipuncture are one of the most common hospital procedures, affecting nearly every hospitalized patient daily.3 A recent Harris Poll highlighted that patients often experience unnecessary, failed and repeat needlesticks in hospitals. In fact, needlesticks are an often-overlooked challenge but can be one of the most traumatic aspects of a patient's hospital stay with more than half of Americans (
Patients and clinicians alike are interested in new technology and solutions to reduce needlesticks and improve the standard of care.
"During my hospital stay, I dreaded the daily blood draws that left my arms bruised and painful," said a 17-year-old pediatric patient who experienced PIVO™ Pro during Carilion's trial period. "When I was introduced to this device, it was a game-changer. It saved me from the pain and tears of multiple needlesticks. It truly transformed my hospital experience, allowing me to focus on getting better without the added stress of painful blood draws. This innovation gave me hope and comfort during a very challenging time."
PIVO™ Pro will be available at Carilion Roanoke Memorial Hospital and will be rolled out to other Carilion hospitals throughout the year. Learn more about Carilion's commitment to compassionate patient care at www.carilionclinic.org.
As the global leader in vascular access solutions, BD is committed to advancing the standard of care for IV therapy and blood draws for patients and health care providers. The PIVO™ Pro technology is part of the company's vision for a "One-Stick Patient Experience" to help minimize the number of needlesticks for patients by using an existing peripheral IV catheter line to collect a high-quality, reliable blood sample through a singular access point.1 For more information about the BD Peripheral Line Draw Solution, including PIVO™ Pro, visit www.bd.com/PIVO.
About Carilion Clinic
Carilion Clinic is a private, not-for-profit healthcare organization headquartered in
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts
Carilion Clinic Corporate Communications
540-525-6041
media@carilionclinic.org
Alyssa Kretlow
BD Corporate Communications
551.238.4391
alyssa.kretlow@bd.com
Sources:
- Pendleton B, LaFaye R. Multicenter study of needle-free blood collection system for reducing specimen error and intravenous catheter replacement. J Healthc Qual. 2022;44(2):e24-e30. doi:10.1097/JHQ.0000000000000331.
- Green SF. The cost of poor blood specimen quality and errors in preanalytical processes. Clin Biochem. 2013;46:1175-1179. doi: 10.1016/j.clinbiochem.2013.06.001.
- Cadacio C, Nachamkin I. A novel needle-free blood draw device for sample collection from short peripheral catheters. J Infus Nurs. 2017:40(3):156-162.
View original content to download multimedia:https://www.prnewswire.com/news-releases/carilion-clinic-first-in-virginia-to-offer-needle-free-in-patient-blood-draws-redefining-patient-standard-of-care-302356789.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
What is the new blood collection technology implemented by BD (BDX) at Carilion Clinic?
How many patients will potentially benefit from BD's (BDX) PIVO™ Pro implementation at Carilion Clinic?
When will BD's (BDX) PIVO™ Pro be available across all Carilion hospitals?
What percentage of Americans could benefit from BD's (BDX) needle-free blood collection technology?
